Preparation method of immunoaffinity chromatography filler, etomidate immunoaffinity enrichment column and etomidate enrichment method
Immunoaffinity chromatography filler is prepared by coupling cyano bromide to activated crosslinked agarose filler with antibodies, which solves the problem of complexity and insufficient selectivity of drug detection in wastewater in the prior art, and achieves efficient and simple etometine Enrichment and detection.
Patent Information
- Application Number
- CN202411304658.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-19
- Publication Date
- 2024-11-22
AI Technical Summary
The existing enrichment technology is complex, long, high cost and poor selectivity when detecting poisons and metabolites in sewage, resulting in limited detection accuracy and repeatability.
The cross-linked agarose filler was activated by cyano bromide in acetonitrile solution, and the antibody was used for coupling reaction to prepare immunoaffinity chromatography filler for enrichment and detection of etomidate.
It improves the enrichment efficiency and detection accuracy, simplifies the operation process, reduces the impurity content, and is suitable for a variety of detection scenarios.
Smart Images

Figure CN118988268A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, and in particular to a method for preparing an immunoaffinity chromatography filler, an etomidate immunoaffinity enrichment column and an etomidate enrichment method. Background Art
[0002] Quantitative and qualitative analysis and detection of human metabolites in urban sewage can be used to objectively evaluate the drug abuse of people in a certain area, so sewage drug testing has great advantages. However, the concentration of drugs and their metabolites in sewage is very low, with the lowest being less than 10ng / L. Conventional testing equipment is difficult to accurately detect drug substances (such as etomidate) in sewage, and must be enriched and concentrated by certain means to achieve qualitative or quantitative testing.
[0003] Existing enrichment technologies include solid phase extraction technology and liquid-liquid extraction technology, which have shortcomings such as complex operation, long extraction time, and high cost. They need to be combined with specific laboratory instruments and equipment to complete the detection. In addition, the above-mentioned enrichment technologies generally achieve the extraction or adsorption of the target through polarity differences or ionic strength, with poor selectivity. Due to the complex composition of the actual water body, there are many impurities after enrichment, which seriously interferes with the accuracy and repeatability of the detection.
[0004] In view of this, the present invention is proposed. Summary of the invention
[0005] The first object of the present invention is to provide a method for preparing an immunoaffinity chromatography filler to solve the above-mentioned problem.
[0006] The second object of the present invention is to provide an etomidate immunoaffinity enrichment column.
[0007] The third object of the present invention is to provide a method for enriching etomidate.
[0008] In order to achieve the above objectives, the following technical solutions are proposed:
[0009] In a first aspect, the present invention provides a method for preparing an immunoaffinity chromatography filler, comprising the following steps:
[0010] a. dissolving cyanogen bromide in acetonitrile and then mixing it with the solution of the cross-linked agarose filler for activation;
[0011] b. mixing the cross-linked agarose filler activated in step a with the antibody solution to perform a coupling reaction;
[0012] c. The cross-linked agarose filler after coupling in step b is sequentially blocked and cleaned to prepare an immunoaffinity chromatography filler.
[0013] As a further technical solution, in step a, cyanogen bromide is dissolved in acetonitrile to obtain an acetonitrile solution of cyanogen bromide, wherein the concentration of cyanogen bromide in the solution is 0.5-2 g / mL;
[0014] The solution of the cross-linked agarose filler is a sodium carbonate solution in which the cross-linked agarose filler is dispersed, and the concentration of sodium carbonate in the solution is 0.8-1.2M;
[0015] In the solution of the cross-linked agarose filler, the concentration of the cross-linked agarose filler is 40% vol-60% vol;
[0016] The volume ratio of the solution of acetonitrile and cross-linked agarose filler is 1:8-1:12.
[0017] As a further technical solution, the temperature of the activation treatment is 20-30°C;
[0018] The activation treatment time is 1.5-2.5 min.
[0019] As a further technical solution, the pH of the coupling reaction is 9-10 and the reaction time is 3.5-4.5 hours.
[0020] As a further technical solution, the blocking treatment includes treating the coupled cross-linked agarose filler with Tris-HCl buffer;
[0021] The concentration of the Tris-HCl buffer is 0.08-0.12 M, and the pH is 7.5-8.5;
[0022] The sealing treatment time is 1.5-2.5h.
[0023] As a further technical solution, the cleaning comprises: first cleaning with a Tris-HCl-NaCl buffer and an acetic acid-sodium acetate-NaCl buffer, and then cleaning with a 15% vol-25% vol ethanol solution;
[0024] Preferably, in the Tris-HCl-NaCl buffer, the concentration of Tris-HCl is 0.08-0.12 M, the concentration of NaCl is 0.4-0.6 M, and the pH is 8.5-9.5;
[0025] Preferably, in the acetic acid-sodium acetate-NaCl buffer, the concentration of acetic acid-sodium acetate is 0.08-0.12 M, the concentration of NaCl is 0.4-0.6 M, and the pH is 2.5-3.5.
[0026] As a further technical solution, in the immunoaffinity chromatography filler, the ratio of the antibody to the cross-linked agarose filler is 0.5 mg:1 mL-5 mg:1 mL.
[0027] As a further technical solution, the antibody comprises etomidate antibody.
[0028] In a second aspect, the present invention provides an etomidate immunoaffinity enrichment column, comprising a column tube, a rubber plug, a rubber stopper, an upper sieve plate, a lower sieve plate and an immunoaffinity chromatography filler;
[0029] The immunoaffinity chromatography filler is prepared by the preparation method;
[0030] The antibody in the immunoaffinity chromatography filler is etomidate antibody.
[0031] In a third aspect, the present invention provides a method for enriching etomidate, comprising: passing a test solution through the etomidate immunoaffinity enrichment column, and then washing and eluting in sequence to obtain an eluate containing etomidate.
[0032] Compared with the prior art, the present invention has the following beneficial effects:
[0033] The preparation method of the immunoaffinity chromatography filler provided by the invention uses an acetonitrile solution of cyanogen bromide to activate the cross-linked agarose filler, so the reaction process is safer and the activation efficiency is high.
[0034] Compared with commonly used solid phase extraction columns, the etomidate immunoaffinity enrichment column provided by the present invention has the advantages of simple pretreatment, fast enrichment flow rate, convenient enrichment process, and a wide range of elution solvents. It can effectively improve the efficiency of enrichment and detection and is suitable for a variety of detection scenarios.
[0035] The method for enriching etomidate provided by the invention is simple and efficient, has good enrichment selectivity and low impurity content. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0037] Figure 1 This is the curve of the enriched product in Example 1 in the liquid chromatography-mass spectrometry test;
[0038] Figure 2 It is an etomidate immunoaffinity enrichment column.
[0039] Icon: 1-column tube; 2-rubber plug; 3-rubber stopper; 4-upper sieve plate; 5-lower sieve plate; 6-immunoaffinity chromatography filler. DETAILED DESCRIPTION
[0040] The embodiments of the present invention will be described in detail below in conjunction with the embodiments and examples, but those skilled in the art will understand that the following embodiments and examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.
[0041] In a first aspect, the present invention provides a method for preparing an immunoaffinity chromatography filler, comprising the following steps:
[0042] a. dissolving cyanogen bromide in acetonitrile and then mixing it with the solution of the cross-linked agarose filler for activation;
[0043] b. mixing the cross-linked agarose filler activated in step a with the antibody solution to perform a coupling reaction;
[0044] c. The cross-linked agarose filler after coupling in step b is sequentially blocked and cleaned to prepare an immunoaffinity chromatography filler.
[0045] The preparation method of the immunoaffinity chromatography filler provided by the present invention uses an acetonitrile solution of cyanogen bromide to activate the cross-linked agarose filler, the reaction process is safer, the activation efficiency is high, and it can be used for the specific enrichment of etomidate and the like, thereby improving the detection precision and accuracy thereof and effectively reducing the detection threshold.
[0046] In some optional embodiments, in step a, cyanogen bromide is dissolved in acetonitrile to obtain an acetonitrile solution of cyanogen bromide, and the concentration of cyanogen bromide in the solution can be, for example, but not limited to, 0.5 g / mL, 1 g / mL, 1.5 g / mL or 2 g / mL;
[0047] The solution of the cross-linked agarose filler is a sodium carbonate solution in which the cross-linked agarose filler is dispersed. The concentration of sodium carbonate in the solution may be, for example, but not limited to, 0.8 M, 1 M or 1.2 M. Sodium carbonate is used to maintain the pH of the solution of the cross-linked agarose filler above 11;
[0048] In the solution of the cross-linked agarose filler, the concentration of the cross-linked agarose filler may be, for example, but not limited to, 40% vol, 50% vol or 60% vol;
[0049] The volume ratio of the solution of acetonitrile and cross-linked agarose filler may be, for example, but not limited to, 1:8, 1:9, 1:10, 1:11 or 1:12.
[0050] In some optional embodiments, the cross-linked agarose filler is first washed with deionized water and 1M sodium carbonate solution and then dispersed in 1M sodium carbonate solution to prepare the cross-linked agarose filler solution.
[0051] In some optional embodiments, the temperature of the activation treatment may be, for example, but not limited to, 20°C, 22°C, 24°C, 26°C, 28°C or 30°C;
[0052] The activation treatment time may be, for example, but not limited to, 1.5 min, 2 min or 2.5 min.
[0053] In some optional embodiments, after the activation treatment, the activated cross-linked agarose filler is first washed with a 0.1 M carbonate buffer at pH 9.6, and then mixed with the antibody solution.
[0054] In some optional embodiments, the antibody solution is prepared by dissolving the antibody in a 0.01 M sodium carbonate-sodium bicarbonate buffer solution at pH = 9.6.
[0055] In some optional embodiments, the pH of the coupling reaction can be, for example, but not limited to 9, 9.6 or 10, and the time can be, for example, but not limited to 4.5 h, 4 h or 4.5 h.
[0056] In some optional embodiments, the blocking treatment includes treating the coupled cross-linked agarose filler with Tris-HCl buffer;
[0057] The concentration of the Tris-HCl buffer may be, for example, but not limited to, 0.08 M, 0.1 M or 0.12 M, and the pH may be, for example, but not limited to, 7.5, 8 or 8.5;
[0058] The sealing treatment time may be, for example, but not limited to, 1.5 h, 2 h or 2.5 h.
[0059] In some optional embodiments, the washing comprises: first washing with a Tris-HCl-NaCl buffer and an acetic acid-sodium acetate-NaCl buffer, and then washing with a 15% vol-25% vol ethanol solution;
[0060] Preferably, in the Tris-HCl-NaCl buffer, the concentration of Tris-HCl may be, for example, but not limited to 0.08M, 0.1M or 0.12M, the concentration of NaCl may be, for example, but not limited to 0.4M, 0.5M or 0.6M, and the pH may be, for example, but not limited to 8.5, 9 or 9.5;
[0061] Preferably, in the acetic acid-sodium acetate-NaCl buffer, the concentration of acetic acid-sodium acetate may be, for example, but not limited to 0.08M, 0.1M or 0.12M, the concentration of NaCl may be, for example, but not limited to 0.4M, 0.5M or 0.6M, and the pH may be, for example, but not limited to 2.5, 3 or 3.5.
[0062] In some optional embodiments, the washing is: firstly washing with Tris-HCl-NaCl buffer and acetic acid-sodium acetate-NaCl buffer for 2 times, and then washing with 20% vol ethanol solution for 2 times.
[0063] In some optional embodiments, in the immunoaffinity chromatography filler, the ratio of the antibody to the cross-linked agarose filler can be, for example, but not limited to, 0.5 mg:1 mL, 1 mg:1 mL, 2 mg:1 mL, 4 mg:1 mL or 5 mg:1 mL.
[0064] In some alternative embodiments, the antibody includes but is not limited to etomidate antibody.
[0065] The immunoaffinity chromatography filler prepared using etomidate antibody as the antibody can be used for the enrichment of etomidate.
[0066] In a second aspect, the present invention provides an etomidate immunoaffinity enrichment column, such as Figure 2 As shown, it comprises a column tube 1, a rubber plug 2, a rubber stopper 3, an upper sieve plate 4, a lower sieve plate 5 and an immunoaffinity chromatography filler 6; wherein the immunoaffinity chromatography filler 6 is filled between the upper sieve plate 4 and the lower sieve plate 5, and protected in a 20% ethanol solution;
[0067] The immunoaffinity chromatography filler 6 is prepared by the preparation method described above;
[0068] The antibody in the immunoaffinity chromatography filler 6 is etomidate antibody.
[0069] Compared with commonly used solid phase extraction columns, the etomidate immunoaffinity enrichment column provided by the present invention has the advantages of simple pretreatment, fast enrichment flow rate, convenient enrichment process, and a wide range of elution solvents. It can effectively improve the efficiency of enrichment and detection and is suitable for a variety of detection scenarios.
[0070] In a third aspect, the present invention provides a method for enriching etomidate, comprising: passing a test solution through the etomidate immunoaffinity enrichment column, and then washing and eluting in sequence to obtain an eluate containing etomidate.
[0071] The method for enriching etomidate provided by the invention is simple and efficient, has good enrichment selectivity and low impurity content.
[0072] In some optional embodiments, the elution solvent used for elution includes an organic elution solvent and an aqueous elution solvent, wherein the organic elution solvent includes but is not limited to methanol, acetonitrile, a methanol-acetonitrile mixture, acetone or isopropanol, and the eluent is suitable for liquid chromatography-mass spectrometry and other tests; the aqueous elution solvent includes but is not limited to 0.1M hydrochloric acid solution or 1M sodium chloride solution, and the eluent is suitable for rapid immune test product testing after neutralization.
[0073] The present invention is further described below by means of specific examples and comparative examples. However, it should be understood that these examples are only used for more detailed description and should not be construed as limiting the present invention in any form.
[0074] In the following examples and comparative examples, the test methods used are as follows:
[0075] 1. Antibody coupling rate detection:
[0076] The absorbance of the supernatant before and after coupling at a wavelength of 280 nm (A280) was measured by UV spectrophotometer. The coupling rate was calculated as follows: 1-A 280,偶联后 / A 280,偶联前 .
[0077] 2. Testing of etomidate in enriched samples
[0078] 2.1 Liquid chromatography-mass spectrometry test
[0079] (1) After the wastewater is enriched and washed, 1 ml of methanol is used to elute the enriched sample, and the peak area of etomidate is tested by liquid chromatography-mass spectrometry.
[0080] (2) Dissolve etomidate standard in methanol to prepare a 5 ng / ml standard solution, and use liquid chromatography-mass spectrometry to test the methamphetamine peak area.
[0081] (3) Based on the ratio of the peak areas of etomidate in the enriched solution and the standard solution, the concentration of the standard in the enriched solution was calculated, and the absolute amount and recovery rate of etomidate were further calculated.
[0082] 3.2 Rapid Immunity Test Product Testing
[0083] After the sewage is enriched and rinsed, the enriched sample is eluted with 0.5 ml of 0.1 M hydrochloric acid, neutralized to neutrality and then dripped onto the rapid immune test product. After waiting for a certain period of time, the test result is read to determine whether it is positive.
[0084] Etomidate immunoaffinity enrichment column, such as Figure 2As shown, it includes a column tube 1, a rubber plug 2, a rubber stopper 3, an upper sieve plate 4, a lower sieve plate 5 and an immunoaffinity chromatography filler 6; wherein the immunoaffinity chromatography filler 6 is filled between the upper sieve plate 4 and the lower sieve plate 5, and protected in a 20% ethanol solution.
[0085] Example 1
[0086] 1. Preparation of etomidate immunoaffinity chromatography medium
[0087] (1) Take 1 mg of etomidate antibody and dialyze it against 0.01 M sodium carbonate-sodium bicarbonate buffer solution at pH = 9.6 until equilibrium.
[0088] (2) Take 10 ml of cross-linked agarose filler, wash it with 100 ml of deionized water and 50 ml of 1 M sodium carbonate solution, filter it, and then disperse it in 1 M sodium carbonate solution. The total volume of the dispersion is 20 ml, and slowly stir it until the dispersion temperature reaches 25°C.
[0089] (3) Dissolve 1 g of cyanogen bromide in 2 ml of acetonitrile, add directly to the agarose filler dispersion, and stir to activate for 2 min.
[0090] (4) The activated cross-linked agarose filler was washed with 0.1 M carbonate buffer (PH = 9.6), filtered, added to the dialyzed antibody solution, and reacted at room temperature for 4 hours.
[0091] (5) The coupled filler was transferred to 0.1 M Tris-HCl buffer (pH = 8.0) and blocked by shaking at room temperature for 2 h.
[0092] (6) After blocking, the filler was washed twice with a Tris-HCl / NaCl (0.1M / 0.5M) buffer solution at pH = 9.0 and an acetic acid-sodium acetate / NaCl (0.1M / 0.5M) buffer solution at pH = 3.0, and then washed twice with 20% ethanol and stored in 20% ethanol for future use.
[0093] (7) The absorbance of the supernatant before and after coupling was tested at a wavelength of 280 nm, and the coupling rate was measured to be 93.2%.
[0094] 2. Etomidate Immunoenrichment Column Installation
[0095] Add the lower sieve plate 5 to the column tube 1, add about 0.3 ml of etomidate affinity filler after compacting, and then press the upper sieve plate 4 to compact the filler, then add 20% ethanol to about 0.6 ml, and install the rubber plug 2 and rubber stopper 3 to seal.
[0096] 3. Etomidate immunoenrichment column enrichment process and test results
[0097] (1) Take 800 ml of sewage containing 8 ng of etomidate and an etomidate concentration of 0.01 ng / mL, filter it and connect it to an enrichment device for enrichment at an enrichment flow rate of 20 ml / min and an enrichment time of 40 min.
[0098] (2) After enrichment, rinse with 3 ml of pure water and drain, then elute with 1 ml of elution solvent to obtain the eluate to be tested.
[0099] (3) Liquid phase mass spectrometry test: 1 ml of methanol was used as the elution solvent. After elution, the sample was directly loaded for testing. The concentration in the eluate was measured to be 5.88 ng / ml, the enrichment recovery rate was 73.5%, and the enrichment concentration factor was 588 times. The liquid phase mass spectrometry test curve of the eluate is as follows: Figure 1 (The horizontal axis in the figure is time, and the unit is min).
[0100] (4) Immunochromatographic product test: The elution solvent is 1 ml of 0.1 M hydrochloric acid solution. After elution, it is neutralized to neutrality and directly tested with a fluorescent immunochromatographic product to be positive.
[0101] Embodiment 2:
[0102] 1. Preparation of etomidate immunoaffinity chromatography medium
[0103] (1) Take 0.5 mg of etomidate antibody and dialyze it against 0.01 M sodium carbonate-sodium bicarbonate buffer solution at pH = 9.6 until equilibrium.
[0104] (2) Take 10 ml of cross-linked agarose filler, wash it with 100 ml of deionized water and 50 ml of 1 M sodium carbonate solution, filter it, and then disperse it in 1 M sodium carbonate solution. The total volume of the dispersion is 20 ml, and slowly stir it until the dispersion temperature reaches 25°C.
[0105] (3) Dissolve 1 g of cyanogen bromide in 2 ml of acetonitrile, add directly to the agarose filler dispersion, and stir to activate for 2 min.
[0106] (4) The activated cross-linked agarose filler was washed with 0.1 M carbonate buffer (PH = 9.6), filtered, added to the dialyzed antibody solution, and reacted at room temperature for 4 hours.
[0107] (5) The coupled filler was transferred to 0.1 M Tris-HCl buffer (pH = 8.0) and blocked by shaking at room temperature for 2 h.
[0108] (6) After blocking, the filler was washed twice with a Tris-HCl / NaCl (0.1M / 0.5M) buffer solution at pH = 9.0 and an acetic acid-sodium acetate / NaCl (0.1M / 0.5M) buffer solution at pH = 3.0, and then washed twice with 20% ethanol and stored in 20% ethanol for future use.
[0109] (7) The absorbance of the supernatant before and after coupling was tested at a wavelength of 280 nm, and the coupling rate was measured to be 96.8%.
[0110] 2. Etomidate Immunoenrichment Column Installation
[0111] Add the lower sieve plate 5 to the column tube 1, add about 0.3 ml of etomidate affinity filler after compacting, and then press the upper sieve plate 4 to compact the filler, then add 20% ethanol to about 0.6 ml, and install the rubber plug 2 and rubber stopper 3 to seal.
[0112] 3. Etomidate immunoenrichment column enrichment process and test results
[0113] (1) Take 2000 ml of sewage containing 20 ng of etomidate and an etomidate concentration of 0.01 ng / mL, filter it and connect it to an enrichment device for enrichment. The enrichment flow rate is 30 ml / min and the enrichment time is 66.7 min.
[0114] (2) After enrichment, rinse with 3 ml of pure water and drain, then elute with 1 ml of elution solvent to obtain the eluate to be tested.
[0115] (3) Liquid phase mass spectrometry test: 1 ml of methanol was used as the elution solvent. The sample was directly loaded for testing after elution. The concentration in the eluate was measured to be 7.28 ng / ml, the enrichment recovery rate was 36.4%, and the enrichment concentration factor was 728 times.
[0116] (4) Immunochromatographic product test: The elution solvent is 1 ml of 0.1 M hydrochloric acid solution. After elution, it is neutralized to neutrality and directly tested with a fluorescent immunochromatographic product to be positive.
[0117] Embodiment 3:
[0118] 1. Preparation of etomidate immunoaffinity chromatography medium
[0119] (1) Take 5 mg of etomidate antibody and dialyze it against 0.01 M sodium carbonate-sodium bicarbonate buffer solution at pH = 9.6 until equilibrium.
[0120] (2) Take 10 ml of cross-linked agarose filler, wash it with 100 ml of deionized water and 50 ml of 1 M sodium carbonate solution, filter it, and then disperse it in 1 M sodium carbonate solution. The total volume of the dispersion is 20 ml, and slowly stir it until the dispersion temperature reaches 25°C.
[0121] (3) Dissolve 1 g of cyanogen bromide in 2 ml of acetonitrile, add directly to the agarose filler dispersion, and stir to activate for 2 min.
[0122] (4) The activated cross-linked agarose filler was washed with 0.1 M carbonate buffer (PH = 9.6), filtered, added to the dialyzed antibody solution, and reacted at room temperature for 4 hours.
[0123] (5) The coupled filler was transferred to 0.1 M Tris-HCl buffer solution at pH 8.0 and blocked by shaking at room temperature for 2 h.
[0124] (6) After blocking, the filler was washed twice with a Tris-HCl / NaCl (0.1M / 0.5M) buffer solution at pH = 9.0 and an acetic acid-sodium acetate / NaCl (0.1M / 0.5M) buffer solution at pH = 3.0, and then washed twice with 20% ethanol and stored in 20% ethanol for future use.
[0125] (7) The absorbance of the supernatant before and after coupling was tested at a wavelength of 280 nm, and the coupling rate was measured to be 83.6%.
[0126] 2. Etomidate Immunoenrichment Column Installation
[0127] Add the lower sieve plate 5 to the column tube 1, add about 0.3 ml of etomidate affinity filler after compacting, and then press the upper sieve plate 4 to compact the filler, then add 20% ethanol to about 0.6 ml, and install the rubber plug 2 and rubber stopper 3 to seal.
[0128] 3. Etomidate immunoenrichment column enrichment process and test results
[0129] (1) Take 300 ml of sewage containing 6 ng of etomidate and an etomidate concentration of 0.02 ng / mL, filter it and connect it to an enrichment device for enrichment at an enrichment flow rate of 10 ml / min and an enrichment time of 30 min.
[0130] (2) After enrichment, rinse with 3 ml of pure water and drain, then elute with 1 ml of elution solvent to obtain the eluate to be tested.
[0131] (3) Liquid phase mass spectrometry test: 1 ml of methanol was used as the elution solvent. The sample was directly loaded for testing after elution. The concentration in the eluate was measured to be 5.21 ng / ml, the enrichment recovery rate was 86.8%, and the enrichment concentration factor was 261 times.
[0132] (4) Immunochromatographic product test: The elution solvent is 1 ml of 0.1 M hydrochloric acid solution. After elution, it is neutralized to neutrality and directly tested with a fluorescent immunochromatographic product to be positive.
[0133] Example 4
[0134] 1. Preparation of etomidate immunoaffinity chromatography medium
[0135] (1) Take 0.5 mg of etomidate antibody and dialyze it against a sodium carbonate-sodium bicarbonate buffer solution at pH 9 until equilibrium.
[0136] (2) Take 6.4 ml of cross-linked agarose filler, wash it with 100 ml of deionized water and 50 ml of 1 M sodium carbonate solution, filter it, and then disperse it in 0.8 M sodium carbonate solution. The total volume of the dispersion is 16 ml, and stir it slowly until the dispersion temperature reaches 20°C.
[0137] (3) Dissolve 2 g of cyanogen bromide in 2 ml of acetonitrile and add directly to the agarose filler dispersion. Stir and activate for 2.5 min.
[0138] (4) The activated cross-linked agarose filler was washed with carbonate buffer (PH=9), filtered, added to the dialyzed antibody solution, and reacted at room temperature for 4.5 hours.
[0139] (5) The coupled filler was transferred to Tris-HCl buffer at pH 7.5 and blocked by shaking at room temperature for 1.5 h.
[0140] (6) After blocking, the filler was washed twice with a Tris-HCl / NaCl buffer solution (NaCl concentration is 0.4 M) at pH 8.5 and an acetic acid-sodium acetate / NaCl buffer solution (NaCl concentration is 0.4 M) at pH 2.5, and then washed twice with 20% ethanol and stored in 20% ethanol for later use.
[0141] (7) The absorbance of the supernatant before and after coupling was tested at a wavelength of 280 nm, and the coupling rate was measured to be 96.8%.
[0142] 2. Etomidate Immunoenrichment Column Installation
[0143] Add the lower sieve plate 5 to the column tube 1, add about 0.3 ml of etomidate affinity filler after compacting, and then press the upper sieve plate 4 to compact the filler, then add 20% ethanol to about 0.6 ml, and install the rubber plug 2 and rubber stopper 3 to seal.
[0144] 3. Etomidate immunoenrichment column enrichment process and test results
[0145] (1) Take 2000 ml of sewage containing 20 ng of etomidate and an etomidate concentration of 0.01 ng / mL, filter it and connect it to an enrichment device for enrichment. The enrichment flow rate is 30 ml / min and the enrichment time is 66.7 min.
[0146] (2) After enrichment, rinse with 3 ml of pure water and drain, then elute with 1 ml of elution solvent to obtain the eluate to be tested.
[0147] (3) Liquid phase mass spectrometry test: 1 ml of methanol was used as the elution solvent. The sample was directly loaded for testing after elution. The concentration in the eluate was measured to be 8.36 ng / ml, the enrichment recovery rate was 41.8%, and the enrichment concentration factor was 836 times.
[0148] (4) Immunochromatographic product test: The elution solvent is 1 ml of 0.1 M hydrochloric acid solution. After elution, it is neutralized to neutrality and directly tested with a fluorescent immunochromatographic product to be positive.
[0149] Example 5
[0150] 1. Preparation of etomidate immunoaffinity chromatography medium
[0151] (1) Take 0.5 mg of etomidate antibody and dialyze it against a sodium carbonate-sodium bicarbonate buffer solution at pH = 10 until equilibrium.
[0152] (2) Take 14.4 ml of cross-linked agarose filler, wash it with 100 ml of deionized water and 50 ml of 1 M sodium carbonate solution, filter it, and then disperse it in 1.2 M sodium carbonate solution. The total volume of the dispersion is 24 ml, and slowly stir it until the dispersion temperature reaches 30°C.
[0153] (3) Dissolve 4 g of cyanogen bromide in 2 ml of acetonitrile and add directly to the agarose filler dispersion. Stir and activate for 1.5 min.
[0154] (4) The activated cross-linked agarose filler was washed with carbonate buffer (PH=10), filtered, added to the dialyzed antibody solution, and reacted at room temperature for 3.5 hours.
[0155] (5) The coupled filler was transferred to Tris-HCl buffer (pH = 8.5) and blocked by shaking at room temperature for 2.5 h.
[0156] (6) After blocking, the filler was washed twice with a Tris-HCl / NaCl buffer solution at pH 9.5 (NaCl concentration is 0.6 M) and an acetic acid-sodium acetate / NaCl buffer solution at pH 3.5 (NaCl concentration is 0.6 M), and then washed twice with 20% ethanol and stored in 20% ethanol for later use.
[0157] (7) The absorbance of the supernatant before and after coupling was tested at a wavelength of 280 nm, and the coupling rate was measured to be 96.8%.
[0158] 2. Etomidate Immunoenrichment Column Installation
[0159] Add the lower sieve plate 5 to the column tube 1, add about 0.3 ml of etomidate affinity filler after compacting, and then press the upper sieve plate 4 to compact the filler, then add 20% ethanol to about 0.6 ml, and install the rubber plug 2 and rubber stopper 3 to seal.
[0160] 3. Etomidate immunoenrichment column enrichment process and test results
[0161] (1) Take 2000 ml of sewage containing 20 ng of etomidate and an etomidate concentration of 0.01 ng / mL, filter it and connect it to an enrichment device for enrichment. The enrichment flow rate is 30 ml / min and the enrichment time is 66.7 min.
[0162] (2) After enrichment, rinse with 3 ml of pure water and drain, then elute with 1 ml of elution solvent to obtain the eluate to be tested.
[0163] (3) Liquid phase mass spectrometry test: 1 ml of methanol was used as the elution solvent. The sample was directly loaded for testing after elution. The concentration in the eluate was measured to be 9.36 ng / ml, the enrichment recovery rate was 46.8%, and the enrichment concentration factor was 936 times.
[0164] (4) Immunochromatographic product test: The elution solvent is 1 ml of 0.1 M hydrochloric acid solution. After elution, it is neutralized to neutrality and directly tested with a fluorescent immunochromatographic product to be positive.
[0165] Comparative Example 1:
[0166] 1. Conventional cyanogen bromide activation and filler coupling experiments:
[0167] (1) Take 1 mg of etomidate antibody and dialyze it against 0.01 M sodium carbonate-sodium bicarbonate buffer solution at pH = 9.6 until equilibrium.
[0168] (2) Take 10 ml of cross-linked agarose filler, wash it with 10 times more deionized water, filter it, and disperse it in deionized water. The total volume of the dispersion is 20 ml. Slowly stir it in an ice water bath until the dispersion temperature reaches below 10°C.
[0169] (3) Take 1g of cyanogen bromide, grind it into powder and add it to the agarose filler dispersion. After it is completely dissolved, continue to slowly add 1 mol / L sodium hydroxide solution to maintain the pH of the system at around 11 until the pH is basically stable. The total activation time is 30 min to 60 min.
[0170] (4) The activated cross-linked agarose filler was washed with 0.1 M carbonate buffer (PH = 9.6), filtered, added to the dialyzed antibody solution, and reacted at room temperature for 4 hours.
[0171] (5) The coupled filler was transferred to 0.1 M Tris-HCl buffer solution at pH 8.0 and blocked by shaking at room temperature for 2 h.
[0172] (6) After blocking, the filler was washed twice with a Tris-HCl / NaCl (0.1M / 0.5M) buffer solution at pH = 9.0 and an acetic acid-sodium acetate / NaCl (0.1M / 0.5M) buffer solution at pH = 3.0, and then washed twice with 20% ethanol and stored in 20% ethanol for future use.
[0173] (7) The absorbance of the supernatant before and after coupling was tested at a wavelength of 280 nm, and the coupling rate was measured to be 89.4%.
[0174] 2. Etomidate Immunoenrichment Column Installation
[0175] Add the lower sieve plate to the column tube, press it tightly, add about 0.3 ml of etomidate affinity filler, and then press the upper sieve plate to make the filler tight, then add 20% ethanol to about 0.6 ml, and install the rubber plug and rubber stopper to seal.
[0176] 3. Etomidate immunoenrichment column enrichment process and test results
[0177] (1) Take 800 ml of sewage containing 8 ng of etomidate and an etomidate concentration of 0.01 ng / mL, filter it and connect it to an enrichment device for enrichment at an enrichment flow rate of 20 ml / min and an enrichment time of 40 min.
[0178] (2) After enrichment, rinse with 3 ml of pure water and drain, then elute with 1 ml of elution solvent to obtain the eluate to be tested.
[0179] (3) Liquid phase mass spectrometry test: 1 ml of methanol was selected as the elution solvent. The sample was directly loaded for testing after elution. The concentration in the eluate was measured to be 5.29 ng / ml, the enrichment recovery rate was 66.1%, and the enrichment concentration factor was 529 times.
[0180] (4) Immunochromatographic product test: The elution solvent is 1 ml of 0.1 M hydrochloric acid solution. After elution, it is neutralized to neutrality and directly tested with a fluorescent immunochromatographic product to be positive.
[0181] Comparative Example 2:
[0182] Solid phase extraction column enrichment recovery test method and test results:
[0183] (1) Take a commercial 1 ml solid phase extraction column (Waters Oasis HLB) and add 1 ml of methanol and 1 ml of pure water in sequence for activation.
[0184] (2) Take 160 ml of sewage containing 8 ng of etomidate and an etomidate concentration of 0.05 ng / mL, filter it and connect it to an enrichment device for enrichment at an enrichment flow rate of 4 ml / min and an enrichment time of 40 min.
[0185] (3) After enrichment, remove residual impurities by rinsing with 2 ml of deionized water, and then elute with 1 ml of methanol solution.
[0186] (4) Liquid phase mass spectrometry test: The solution after methanol elution was directly injected for testing, and the concentration of etomidate was measured to be 5.34 ng / ml, the enrichment recovery rate was 66.8%, and the enrichment concentration multiple was 107 times.
[0187] (5) Immunochromatography product test: After methanol elution, blow liquid nitrogen for 25 minutes until it is almost dry, then add 0.5 ml of pure water to reconstitute, and test with a fluorescent immunochromatography product to test positive.
[0188] Table 1 LC-MS test results for comparative examples and examples
[0189]
[0190] It can be seen from the above experiment that the coupling rate of the antibody in Example 1 and Comparative Example 1 is about 90%, which is basically equivalent; the recovery rate of the enrichment after column loading is more than 60%, and the difference is small. The above results show that the activation effect of the cyanogen bromide activation method of the present invention is basically the same as that of the conventional method. However, compared with Example 1, the activation time in Comparative Example 1 is as long as 30min to 60min, and alkali solution needs to be continuously added during the period, and the activation efficiency is low; at the same time, since the activator cyanogen bromide is a highly toxic and volatile agent, the scheme of Comparative Example 1 requires the operator to be exposed to an environment containing cyanogen bromide for a long time, the experimental safety risk is high, and the operation is complicated. The present invention uses acetonitrile as a solvent for cyanogen bromide, dissolves cyanogen bromide in a closed container, and the activation time only takes 2min, which improves the efficiency and safety of the experimental operation.
[0191] The test results of Example 1 are compared with those of Comparative Example 2. Under the conditions that the total amount of etomidate in the wastewater to be tested is the same as the enrichment time, the enrichment recovery rates of the two are comparable, but the enrichment flow rate of the immunoaffinity enrichment column is 5 times that of the solid phase extraction column, and the total amount of wastewater enriched in the same time is large, so the final enrichment and concentration multiple reaches more than 5 times that of Comparative Example 1, that is, the detection threshold that the immunoaffinity enrichment column of the present invention can reach is significantly lower than that of the commercial solid phase extraction column. At the same time, the immunoaffinity enrichment column of the present invention can be eluted using organic eluents and inorganic eluents, which are respectively suitable for instrumental tests such as liquid phase mass spectrometry and rapid tests such as immunochromatography, while the solid phase extraction column of Comparative Example 1 can only use organic eluents. If a rapid test is to be performed, it must be dried and redissolved through a cumbersome nitrogen blowing process before testing, and the test process is complicated.
[0192] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for preparing an immunoaffinity chromatography filler, characterized in that: The following steps are involved: a. dissolving cyanogen bromide in acetonitrile and then mixing it with the solution of the cross-linked agarose filler for activation; b. mixing the cross-linked agarose filler activated in step a with the antibody solution to perform a coupling reaction; c. The cross-linked agarose filler after coupling in step b is sequentially blocked and cleaned to prepare an immunoaffinity chromatography filler.
2. The preparation method according to claim 1, characterized in that: In step a, cyanogen bromide is dissolved in acetonitrile to obtain an acetonitrile solution of cyanogen bromide, wherein the concentration of cyanogen bromide in the solution is 0.5-2 g / mL; The solution of the cross-linked agarose filler is a sodium carbonate solution in which the cross-linked agarose filler is dispersed, and the concentration of sodium carbonate in the solution is 0.8-1.2M; In the solution of the cross-linked agarose filler, the concentration of the cross-linked agarose filler is 40% vol-60% vol; The volume ratio of the solution of acetonitrile and cross-linked agarose filler is 1:8-1:
12.
3. The preparation method according to claim 1, characterized in that: The temperature of the activation treatment is 20-30°C; The activation treatment time is 1.5-2.5 min.
4. The preparation method according to claim 1, characterized in that: The pH of the coupling reaction is 9-10, and the reaction time is 3.5-4.5 hours.
5. The preparation method according to claim 1, characterized in that: The blocking treatment comprises treating the coupled cross-linked agarose filler with Tris-HCl buffer; The concentration of the Tris-HCl buffer is 0.08-0.12 M, and the pH is 7.5-8.5; The sealing treatment time is 1.5-2.5h.
6. The preparation method according to claim 1, characterized in that: The cleaning comprises: firstly cleaning with a Tris-HCl-NaCl buffer and an acetic acid-sodium acetate-NaCl buffer, and then cleaning with a 15% vol-25% vol ethanol solution; Preferably, in the Tris-HCl-NaCl buffer, the concentration of Tris-HCl is 0.08-0.12 M, the concentration of NaCl is 0.4-0.6 M, and the pH is 8.5-9.5; Preferably, in the acetic acid-sodium acetate-NaCl buffer, the concentration of acetic acid-sodium acetate is 0.08-0.12 M, the concentration of NaCl is 0.4-0.6 M, and the pH is 2.5-3.
5.
7. The preparation method according to claim 1, characterized in that: In the immunoaffinity chromatography filler, the ratio of the antibody to the cross-linked agarose filler is 0.5 mg:1 mL-5 mg:1 mL.
8. The preparation method according to claim 1, characterized in that: The antibodies include etomidate antibodies.
9. An etomidate immunoaffinity enrichment column, characterized in that: It includes a column tube, a rubber plug, a rubber stopper, an upper sieve plate, a lower sieve plate and an immunoaffinity chromatography filler; The immunoaffinity chromatography filler is prepared by the preparation method according to any one of claims 1 to 8; The antibody in the immunoaffinity chromatography filler is etomidate antibody.
10. A method for enriching etomidate, characterized in that: include: The solution to be tested is passed through the etomidate immunoaffinity enrichment column of claim 9, and then washed and eluted in sequence to obtain an eluate containing etomidate.
Citation Information
Patent Citations
Method for producing algae toxin immune affinity chromatographic column and use method thereof
CN101134161A
Kit for enriching drug components in sewage, enriching method and determination method
CN118566491A
Method for enriching antibody by using affinity chromatography medium and use thereof
WO2023103005A1
